Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs

2009 ◽  
Vol 9 (3) ◽  
pp. 620-628 ◽  
Author(s):  
L. M. Kucirka ◽  
C. Alexander ◽  
R. Namuyinga ◽  
C. Hanrahan ◽  
R. A. Montgomery ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
High Risk ◽  
Nucleic Acid Testing ◽  
Viral Nucleic Acid ◽  
Donor Organs

scholarly journals Provider Utilization of High-Risk Donor Organs and Nucleic Acid Testing: Results of Two National Surveys

2009 ◽  
Vol 9 (5) ◽  
pp. 1197-1204 ◽  
Author(s):  
L. M. Kucirka ◽  
R. Namuyinga ◽  
C. Hanrahan ◽  
R. A. Montgomery ◽  
D. L. Segev
Keyword(s):  
Nucleic Acid ◽  
High Risk ◽  
Nucleic Acid Testing ◽  
National Surveys ◽  
Donor Organs

Diagnostic Tools for Coronavirus Disease (COVID-19): Comparing CT and RT-PCR Viral Nucleic Acid Testing

2020 ◽  
Vol 215 (4) ◽  
pp. 834-838 ◽  
Author(s):  
Joseph V. Waller ◽  
Parveer Kaur ◽  
Amy Tucker ◽  
Keldon K. Lin ◽  
Michael J. Diaz ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
Diagnostic Tools ◽  
Nucleic Acid Testing ◽  
Rt Pcr ◽  
Viral Nucleic Acid

A fully-integrated and automated testing device for PCR-free viral nucleic acid detection in whole blood

Lab on a Chip ◽  
2018 ◽  
Vol 18 (13) ◽  
pp. 1928-1935 ◽  
Author(s):  
Wenhan Liu ◽  
Jagotamoy Das ◽  
Adam H. Mepham ◽  
Carine R. Nemr ◽  
Edward H. Sargent ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Nucleic Acid ◽  
Disease Diagnosis ◽  
Automated Testing ◽  
Nucleic Acid Detection ◽  
Nucleic Acid Testing ◽  
Testing Device ◽  
Viral Nucleic Acid ◽  
Fully Integrated ◽  
Integrated Devices

Integrated devices for automated nucleic acid testing (NAT) are critical for infectious disease diagnosis to be performed outside of centralized laboratories.

Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools

Transfusion ◽  
2008 ◽  
Vol 48 (5) ◽  
pp. 822-826 ◽  
Author(s):  
C. Micha Nübling ◽  
Uwe Unkelbach ◽  
Michael Chudy ◽  
Rainer Seitz
Keyword(s):  
Nucleic Acid ◽  
Nucleic Acid Testing ◽  
Viral Nucleic Acid

scholarly journals Statistical methods for batch screening of input populations by stage and group in COVID-19 nucleic acid testing

2020 ◽  
Author(s):  
Cheng Yuan Yuan
Keyword(s):  
Nucleic Acid ◽  
High Risk ◽  
Sample Size ◽  
Nasopharyngeal Swab ◽  
Nucleic Acid Testing ◽  
Test Results ◽  
Risk Of Infection ◽  
Positive Group ◽  
Second Stage ◽  
Test Result

AbstractPurposeTo screen for COVID-19 patients in immigration using minimal nucleic acid testing (NAT).MethodsIn the first phase, nasopharyngeal swab samples from the inbound population were numbered and grouped. The samples in the group were mixed together, and a NAT test was performed. When the test result is negative, it means that everyone in the group is not infected and the screening of the group is complete. When the test results were positive, the group moved on to the second stage. In the second stage, all samples in the positive group will be tested individually for NAT.ResultsThe advantages and considerations of the method are discussed. Prevalence in the incoming population was a determinant of the sample size within the group. The lower the incidence, the larger the sample size within the group, the higher the savings in NAT and testing costs.ConclusionThis method has significant efficiency and cost advantages in COVID-19 screening. It can also be used to screen other populations, such as community populations and people at high risk of infection, etc.

scholarly journals A fully automated centrifugal microfluidic system for sample-to-answer viral nucleic acid testing

2020 ◽  
Vol 63 (10) ◽  
pp. 1498-1506 ◽  
Author(s):  
Fei Tian ◽  
Chao Liu ◽  
Jinqi Deng ◽  
Ziwei Han ◽  
Lu Zhang ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
Microfluidic System ◽  
Nucleic Acid Testing ◽  
Viral Nucleic Acid

scholarly journals Antibody and Viral Nucleic Acid Testing of Serum and Cerebrospinal Fluid for Diagnosis of Eastern Equine Encephalitis

2015 ◽  
Vol 53 (8) ◽  
pp. 2768-2772 ◽  
Author(s):  
James A. Sherwood ◽  
David C. Brittain ◽  
John J. Howard ◽  
JoAnne Oliver
Keyword(s):  
Cerebrospinal Fluid ◽  
Nucleic Acid ◽  
Sensitivity And Specificity ◽  
Serum Antibody ◽  
Nucleic Acid Testing ◽  
Antibody Testing ◽  
Viral Nucleic Acid ◽  
Eastern Equine Encephalitis ◽  
Serum Testing

Eastern equine encephalitis diagnostic serum antibody can appear 6 days after the onset of symptoms, and its numbers can increase 4-fold in 4 days, arguing for early and frequent serum testing. In populations where cerebrospinal fluid viral nucleic acid testing sensitivity and specificity remain undetermined, cerebrospinal antibody testing should also be performed.

Sign in / Sign up

Export Citation Format

Share Document